128 related articles for article (PubMed ID: 17455637)
1. [PK/PD of antimicrobials].
Totsuka K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():311-4. PubMed ID: 17455637
[No Abstract] [Full Text] [Related]
2. Tools to define the relevance of PK/PD parameters to the efficacy, toxicity and emergence of resistance of antimicrobials.
Hickey E
Curr Opin Drug Discov Devel; 2007 Jan; 10(1):49-52. PubMed ID: 17265741
[TBL] [Abstract][Full Text] [Related]
3. [To overcome new antibiotic-resistant bacteria].
Ohta M
Nihon Rinsho; 2003 Mar; 61 Suppl 3():153-7. PubMed ID: 12717964
[No Abstract] [Full Text] [Related]
4. Optimizing dosage to prevent emergence of resistance - lessons from in vitro models.
Singh R; Tam VH
Curr Opin Pharmacol; 2011 Oct; 11(5):453-6. PubMed ID: 21868287
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics and antibiotic resistance genes in natural environments.
MartÃnez JL
Science; 2008 Jul; 321(5887):365-7. PubMed ID: 18635792
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration.
Gould IM; MacKenzie FM
Symp Ser Soc Appl Microbiol; 2002; (31):78S-84S. PubMed ID: 12481832
[TBL] [Abstract][Full Text] [Related]
7. Genetics of antimicrobial resistance.
Harbottle H; Thakur S; Zhao S; White DG
Anim Biotechnol; 2006; 17(2):111-24. PubMed ID: 17127523
[TBL] [Abstract][Full Text] [Related]
8. [How do bacteria acquire the resistance to antibiotics].
Ohno A
Nihon Rinsho; 2003 Mar; 61 Suppl 3():158-63. PubMed ID: 12717965
[No Abstract] [Full Text] [Related]
9. [Principles of treatment of infectious diseases with antimicrobial agents].
Hiramatsu K; Kadota J
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():307-10. PubMed ID: 17455636
[No Abstract] [Full Text] [Related]
10. Antimicrobial drug resistance.
Martinez M; Silley P
Handb Exp Pharmacol; 2010; (199):227-64. PubMed ID: 20204590
[TBL] [Abstract][Full Text] [Related]
11. A network-based approach for resistance transmission in bacterial populations.
Gehring R; Schumm P; Youssef M; Scoglio C
J Theor Biol; 2010 Jan; 262(1):97-106. PubMed ID: 19747924
[TBL] [Abstract][Full Text] [Related]
12. [Appropriate use of antimicrobial agents].
Nasu M; Nagai H
Nihon Rinsho; 2003 Feb; 61 Suppl 2():718-23. PubMed ID: 12722306
[No Abstract] [Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposure.
Wu B; Derendorf H
Pharmazie; 2010 Jun; 65(6):417-20. PubMed ID: 20614689
[TBL] [Abstract][Full Text] [Related]
14. [Innovation in anti-bacterial chemotherapy. 2. Introduction of the concept of PK/OD into anti-bacterial chemotherapy].
Totsuka K
Nihon Naika Gakkai Zasshi; 2003 Nov; 92(11):2187-91. PubMed ID: 14679812
[No Abstract] [Full Text] [Related]
15. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
[TBL] [Abstract][Full Text] [Related]
16. Minimum inhibitory concentrations and postantimicrobial effects as factors in dosage of antimicrobial drugs.
Brown SA
J Am Vet Med Assoc; 1987 Oct; 191(7):871-2. PubMed ID: 3316140
[No Abstract] [Full Text] [Related]
17. Can pharmacokinetic-pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?
Courvalin P
Clin Microbiol Infect; 2008 Nov; 14(11):989-94. PubMed ID: 19040470
[TBL] [Abstract][Full Text] [Related]
18. Intelligent dosing of antimicrobials.
Nightingale CH; Quintiliani R; Nicolau DP
Curr Clin Top Infect Dis; 1994; 14():252-65. PubMed ID: 8086120
[No Abstract] [Full Text] [Related]
19. [Optimization of antimicrobial therapy based on therapeutic drug monitoring].
Morita K
Yakugaku Zasshi; 2011; 131(10):1407-13. PubMed ID: 21963966
[TBL] [Abstract][Full Text] [Related]
20. Holding back the tide of antibiotic resistance.
Wolfson W
Chem Biol; 2006 Jan; 13(1):1-3. PubMed ID: 16426963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
